Acurion

Stub active Updated Apr 3, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location San Diego, CA
Latest Stage Seed
Total Raised $4.3M
Website https://www.acurion.com
Sector
biotech AI healthcare

Founders

Rick Fultz CEO
Ludmil Alexandrov Co-Founder & Chief Scientific Officer

About

Acurion is a San Diego-based precision oncology company developing AI-powered image analysis tools for biomarker detection 1. The company’s OncoGaze platform extracts cancer biomarker insights from routine pathology slides prepared during standard clinical care, enabling scalable access to precision medicine without requiring additional tissue or specialized molecular testing 1.

Funding History

Date Round Amount Lead Co-investors
2026-04-02 Seed $4.3M TK & Partners Mesa Verde Venture Partners, National Foundation for Cancer Research, Asian Fund for Cancer Research, Bootstrap Ventures 1

The round was oversubscribed against a $4M target 1. Proceeds will support clinical validation, platform development, regulatory preparation, and commercialization 1.

What Investors Say

No verified investor quotes available at this time.

What Founders Say

No verified founder quotes available at this time.

Sources

  1. PR Newswire, “Acurion Closes Oversubscribed $4.3 Million Seed Round to Advance AI-Driven Precision Oncology Platform,” April 2, 2026. https://www.prnewswire.com/news-releases/acurion-closes-oversubscribed-4-3-million-seed-round-to-advance-ai-driven-precision-oncology-platform-302733064.html↩↩↩↩↩